Borgmann-Staudt A, Jantke A, Hinz S, Beckmann M, Dittrich R, Lotz L, Balcerek M (2023)
Publication Type: Journal article
Publication year: 2023
DOI: 10.1055/a-2081-0605
A possible negative consequence of cancer treatment is the fertility impairment of young cancer survivors. However, most former patients express the wish to have biological children. Fertility-preserving measures are available and are - under certain circumstances - financed by health insurance. Separate information at the time of diagnosis and during follow-up care should be adapted to the individual risk and enable those affected to make a self-determined decision about cryopreservation of germ cells or germ cell tissue. Hyopgonadotropic hypogonadism can be treated by the pulsatile administration of gonadotropins. Affected individuals can be reassured. A health restriction of the offspring due to the cancer treatment is not to be expected, even after artificial insemination.
APA:
Borgmann-Staudt, A., Jantke, A., Hinz, S., Beckmann, M., Dittrich, R., Lotz, L., & Balcerek, M. (2023). S1 Guideline: Impairment of gonadal function after Cancer in Childhood and Adolescence. Klinische Pädiatrie. https://doi.org/10.1055/a-2081-0605
MLA:
Borgmann-Staudt, Anja, et al. "S1 Guideline: Impairment of gonadal function after Cancer in Childhood and Adolescence." Klinische Pädiatrie (2023).
BibTeX: Download